CXCL12 and B-cell chronic lymphocytic leukemia: To confirm that the ibrutinib treatment was effective, we similarly treated CLL cells with or without ibrutinib prior to culture in media with or without the chemokine CXCL12, which can enhance expression and release of MMP-9 from CLL cells [7, 20, 21].